跳转至内容
Merck

SAB4200010

Sigma-Aldrich

Anti-Leupaxin (N-terminal) antibody produced in rabbit

enhanced validation

affinity isolated antibody, buffered aqueous solution

别名:

Anti-LDPL, Anti-LPXN

登录查看公司和协议定价


About This Item

分類程式碼代碼:
12352203
NACRES:
NA.41

生物源

rabbit

共軛

unconjugated

抗體表格

affinity isolated antibody

抗體產品種類

primary antibodies

無性繁殖

polyclonal

形狀

buffered aqueous solution

分子量

antigen ~43 kDa

物種活性

human

加強驗證

recombinant expression
Learn more about Antibody Enhanced Validation

技術

western blot: 1-2 μg/mL using extracts of Raji cells

UniProt登錄號

運輸包裝

dry ice

儲存溫度

−20°C

目標翻譯後修改

unmodified

基因資訊

human ... LPXN(9404)

一般說明

Leupaxin gene is mapped to human chromosome 11q12.1. Leupaxin belongs to the paxillin protein family It is mainly expressed in macrophages, lymphoid tissues and hematopoietic cells. Leupaxin comprises two types of protein interaction domains, LIM domain and leucine−aspartate (LD) motifs. LIM domains mediate localization to focal contacts. LD motifs facilitates focal adhesion kinase (FAK) and vinculin binding, resulting in the localization of focal adhesion kinase (FAK) to focal adhesions. The C-terminal LIM domains in leupaxin share 70% amino acid identity with paxillin. The N-terminal region of leupaxin comprises three short stretches of 13 amino acids that share 70− 90% similarity with paxillin LD motifs.

特異性

Anti-Leupaxin (N-terminal) specifically recognizes human leupaxin.

應用

Anti-Leupaxin antibody produced in rabbit has been used in immunoblotting and proximity ligation assay.

生化/生理作用

Leupaxin in association with a second focal adhesion kinase (FAK) family member, PYK2, acts a cell type-specific signaling complex regulator in leukocytes. It acts as a tyrosine kinase substrate in lymphoid cells and thus, may function in and be regulated by tyrosine kinase activity. Leupaxin facilitates adhesion and invasion of prostate carcinoma cells. It can form a complex with PYK2 and PTP-PEST in various cells such as monocytes and osteoclasts and in prostate cancer cells. In osteoclasts, leupaxin acts as a key nucleating component of the osteoclast podosomal signaling complex in the adhesion zone.

外觀

Solution in 0.01 M phos­phate buffered saline, pH 7.4, containing 15 mM sodium azide.

儲存和穩定性

Store at –20 °C. For continuous use, the product may be stored at 2–8 °C for up to one month. For extended storage, freeze at –20 °C in working aliquots. Repeated freezing and thawing, or storage in “frost-free” freezers, is not recommended. If slight turbidity occurs upon prolonged storage, clarify the solution by centrifugation before use. Working dilutions should be discarded if not used within 12 hours.

免責聲明

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Not finding the right product?  

Try our 产品选型工具.

儲存類別代碼

10 - Combustible liquids

閃點(°F)

Not applicable

閃點(°C)

Not applicable


分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Leupaxin stimulates adhesion and migration of prostate cancer cells through modulation of the phosphorylation status of the actin-binding protein caldesmon
Dierks S, et al.
Oncotarget, 6(15), 13591-13591 (2015)
Structural basis for the interaction between Pyk2-FAT domain and leupaxin LD repeats
Vanarotti MS, et al.
Biochemistry, 55(9), 1332-1345 (2016)
Leupaxin promotes bladder cancer proliferation, metastasis, and angiogenesis through the PI3K/AKT pathway
Hou T, et al.
Cellular Physiology and Biochemistry, 47(6), 2250-2260 (2018)
Leupaxin, a novel coactivator of the androgen receptor, is expressed in prostate cancer and plays a role in adhesion and invasion of prostate carcinoma cells
Kaulfuss S, et al.
Molecular Endocrinology, 22(7), 1606-1621 (2008)
Sascha Dierks et al.
Oncotarget, 6(15), 13591-13606 (2015-06-17)
The focal adhesion protein leupaxin (LPXN) is overexpressed in a subset of prostate cancers (PCa) and is involved in the progression of PCa. In the present study, we analyzed the LPXN-mediated adhesive and cytoskeletal changes during PCa progression. We identified

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门